Announcement • Jun 09
Moliera2 S.A., Annual General Meeting, Jun 30, 2026 Moliera2 S.A., Annual General Meeting, Jun 30, 2026. New Risk • May 26
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł6.2m free cash flow). Share price has been highly volatile over the past 3 months (61% average weekly change). Earnings have declined by 45% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported September 2025 fiscal period end). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€11.5m market cap, or US$13.3m). Announcement • Feb 09
Moliera2 S.A. to Report Q4, 2025 Results on Feb 11, 2026 Moliera2 S.A. announced that they will report Q4, 2025 results on Feb 11, 2026 Announcement • Nov 06
Moliera2 S.A. to Report Q3, 2025 Results on Nov 06, 2025 Moliera2 S.A. announced that they will report Q3, 2025 results on Nov 06, 2025 Reported Earnings • Nov 10
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: zł19.5m (flat on 3Q 2023). Net loss: zł4.42m (loss narrowed 11% from 3Q 2023). Buy Or Sell Opportunity • Oct 30
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 15% to €0.0075. The fair value is estimated to be €0.0061, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 51% over the last 3 years. Meanwhile, the company became loss making. New Risk • Sep 16
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (137% average daily change). Market cap is less than US$10m (€6.00m market cap, or US$6.67m). Minor Risk Shareholders have been diluted in the past year (11% increase in shares outstanding). Buy Or Sell Opportunity • Aug 01
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 1,200% to €0.0065. The fair value is estimated to be €0.0054, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 51% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Jul 01
Now 25% overvalued Over the last 90 days, the stock has fallen 44% to €0.007. The fair value is estimated to be €0.0056, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 51% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Jun 17
Now 20% overvalued Over the last 90 days, the stock has fallen 51% to €0.0065. The fair value is estimated to be €0.0054, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 51% over the last 3 years. Meanwhile, the company became loss making. Announcement • Jun 05
Moliera2 S.A., Annual General Meeting, Jun 27, 2024 Moliera2 S.A., Annual General Meeting, Jun 27, 2024. Buy Or Sell Opportunity • May 31
Now 30% overvalued Over the last 90 days, the stock has fallen 38% to €0.008. The fair value is estimated to be €0.0062, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 51% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • May 06
Now 46% overvalued The stock has been flat over the last 90 days, currently trading at €0.011. The fair value is estimated to be €0.0072, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 51% over the last 3 years. Meanwhile, the company became loss making. New Risk • Apr 09
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.12m (US$9.90m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (68% average weekly change). Earnings have declined by 42% per year over the past 5 years. Market cap is less than US$10m (€9.12m market cap, or US$9.90m). Minor Risk Shareholders have been diluted in the past year (12% increase in shares outstanding). Reported Earnings • Feb 14
Full year 2023 earnings released: zł0.039 loss per share (vs zł0.03 loss in FY 2022) Full year 2023 results: zł0.039 loss per share (further deteriorated from zł0.03 loss in FY 2022). Revenue: zł87.5m (down 30% from FY 2022). Net loss: zł15.0m (loss widened 27% from FY 2022). New Risk • Jan 19
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (36% average weekly change). Earnings have declined by 39% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (4.1% increase in shares outstanding). Market cap is less than US$100m (€10.2m market cap, or US$11.1m). Reported Earnings • Nov 19
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: zł19.5m (down 43% from 3Q 2022). Net loss: zł4.99m (loss widened 128% from 3Q 2022). New Risk • Aug 18
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €8.21m (US$8.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł9.4m free cash flow). Share price has been highly volatile over the past 3 months (78% average weekly change). Earnings have declined by 15% per year over the past 5 years. Market cap is less than US$10m (€8.21m market cap, or US$8.92m). Announcement • Jun 04
Moliera2 S.A., Annual General Meeting, Jun 30, 2023 Moliera2 S.A., Annual General Meeting, Jun 30, 2023, at 11:00 Central European Standard Time. Announcement • Jun 08
Moliera2 SA, Annual General Meeting, Jun 30, 2022 Moliera2 SA, Annual General Meeting, Jun 30, 2022, at 15:00 Central European Standard Time. Reported Earnings • Feb 16
Full year 2021 earnings: Revenues in line with analyst expectations Full year 2021 results: Revenue: zł44.8m (up 191% from FY 2020). Net loss: zł728.2k (down 106% from profit in FY 2020). Revenue was in line with analyst estimates. Announcement • Aug 05
Modern Commerce S.A. has completed a Follow-on Equity Offering in the amount of PLN 79.99074 million. Modern Commerce S.A. has completed a Follow-on Equity Offering in the amount of PLN 79.99074 million.
Security Name: O Shares
Security Type: Common Stock
Securities Offered: 148,131,000
Price\Range: PLN 0.54
Transaction Features: Subsequent Direct Listing Announcement • May 25
Modern Commerce S.A. (WSE:MCE) agreed to acquire IT Fashion Polska Sp. z o.o. for PLN 100 million. Modern Commerce S.A. (WSE:MCE) agreed to acquire IT Fashion Polska Sp. z o.o. for PLN 100 million on May 21, 2021. As of May 24, 2021, out of the amount of PLN 100 million, cash payment would account for PLN 60 million, while the remainder would be paid with equity and at a later date depending on the execution of annual sales plans. For the year ending December 31, 2020, IT Fashion Polska had revenues of PLN 76.8 million. Current owner will stay in the firm, while the new owners announced continuation of the business model with some changes. 
